Neonatal-6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the lesch-nyhan syndrome
- 30 September 1984
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 21 (3), 459-461
- https://doi.org/10.1016/s0091-3057(84)80110-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan SyndromeNew England Journal of Medicine, 1981
- Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activityPsychopharmacology, 1981
- Clinical and biochemical studies on treatment of Lesch-Nyhan syndromeArchives of Disease in Childhood, 1974
- Biochemical and behavioural alterations following 6-hydroxydopamine administration into brainBiochemical Pharmacology, 1974
- Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopaminePharmacology Biochemistry and Behavior, 1973
- Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6‐hydroxydopamineBritish Journal of Pharmacology, 1972
- Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine SynthesisScience, 1967
- A familial disorder of uric acid metabolism and central nervous system functionAmerican Journal Of Medicine, 1964